분무 건조 생물학적 제제 시장 보고서(2026년)
Spray-Dried Biologics Global Market Report 2026
상품코드 : 1957828
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,822,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,861,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,900,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

분무 건조 생물학적 제제 시장 규모는 최근 급성장하고 있습니다. 2025년 18억 6,000만 달러에서 2026년에는 20억 8,000만 달러에 이르고, CAGR 11.7%의 성장이 전망되고 있습니다. 지금까지의 성장은 생물학적 제제의 제제 과학의 발전, 생물학적 제제의 승인 증가, 약물 안정성 개선의 필요성, 백신 제조 능력의 확대, 첨단 제약 가공 기술의 채택에 기인하는 것으로 보입니다.

분무 건조 생물학적 제제 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 32억 달러에 이르고, CAGR은 11.4%를 나타낼 전망입니다. 예측 기간 동안의 성장은 비주사형 생물학적 제제에 대한 수요 증가, 건조 분말 제제 시스템에 대한 투자 확대, 세계 백신 생산 확대, 콜드체인 감소에 대한 관심 증가, 분무 건조 장비 설계의 발전에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 생물학적 제제의 안정성 확보를 위한 분무 건조 기술 채택 확대, 흡입 및 경구용 생물학적 제제 수요 증가, 연속 분무 건조 공정의 확대, 백신의 건조 분말 생물학적 제제 사용 증가, 보존 기간 연장에 대한 관심 증가 등을 들 수 있습니다.

바이오의약품에 대한 수요 증가는 분무건조 바이오의약품 시장의 확대를 촉진할 것으로 예측됩니다. 바이오의약품은 생세포, 단백질, 각종 생체분자 등 생물 유래의 치료제품을 말합니다. 전 세계적으로 만성질환과 복합질환이 증가함에 따라 바이오의약품의 필요성이 증가하고 있으며, 보다 정밀하고 효과적이며 전신 부작용이 적은 치료법에 대한 수요가 증가하고 있습니다. 바이오의약품의 급속한 성장에 따라 안정성 향상, 저장기간 연장, 전달 효율 최적화를 실현하는 확장 가능한 제제법이 기업들에게 요구되면서 분무건조 바이오의약품 분야에 대한 관심이 높아지고 있습니다. 예를 들어, 2025년 2월 스위스에 본부를 둔 세계보건기구(WHO)는 2023년판 필수의약품 목록(EML)에 81종의 생물학적 제제가 등재되어 전체 필수의약품의 15% 이상을 차지했다고 보고했습니다. 이처럼 바이오의약품에 대한 수요 급증은 분무건조 바이오의약품 시장의 성장을 견인하고 있습니다.

분무건조 바이오의약품 시장의 주요 기업들은 투약량 정확도 향상, 분말 처리 효율 향상, 신뢰할 수 있는 대량 캡슐 충전을 실현하는 드럼 투약 기술 등의 기술 혁신을 우선적으로 추진하고 있습니다. 드럼 투약 기술은 정밀하게 설계된 투약 캐비티를 갖춘 회전 드럼과 진공 보조 이송을 채택한 첨단 분말 충전 기술로, 건조 분말을 고정밀도로 계량 및 캡슐화하여 충전합니다. 이를 통해 균일한 저용량 충전, 분무 건조 분말의 우수한 유동성 제어, 확장 가능한 고처리량 운영 등의 특징을 실현합니다. 예를 들어, 2024년 2월, 미국에 본사를 둔 위탁개발제조기관(CDMO)인 Catalent는 드럼 기반 투약 시스템과 인라인 첨단 질량 검증 기술을 활용한 고활성 캡슐 충전 기능을 통합하여 미국 내 흡입제 제조 시설을 강화했습니다. 이 업그레이드된 플랫폼은 설계 분말 및 분무 건조 분말의 정밀 충전을 지원하며, 실시간 투여량 검증 및 제어된 저습도 처리를 내장하고 있습니다. 이번 개선으로 생산 효율성, 제품 균일성 및 분무 건조 생물학적 제제의 건조 분말 흡입 요법의 상업적 규모 생산을 위한 준비 태세를 강화했습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

LSH
영문 목차

영문목차

Spray-dried biologics are biologic drugs that have been converted from a liquid into a dry powder through a rapid drying method. The process involves spraying the liquid formulation into heated air, which rapidly eliminates moisture while preserving the integrity of sensitive components such as proteins, vaccines, or enzymes. The resulting dry form provides benefits such as improved stability, easier handling, and compatibility with various delivery routes.

The primary product categories for spray-dried biologics encompass monoclonal antibodies, vaccines, enzymes, hormones, and additional types. Monoclonal antibodies consist of lab-engineered molecules that precisely identify and attach to particular target antigens. The various administration methods include oral, inhalation or pulmonary, injectable, and topical routes, which cater to end-users like hospitals, research institutes, pharmaceutical and biotechnology companies, and others.

Tariffs are influencing the spray-dried biologics market by increasing costs of imported spray dryers, stainless steel processing components, filtration systems, and analytical instruments used in biologic drug manufacturing. Pharmaceutical manufacturers in North America and Europe are most affected due to reliance on specialized imported equipment, while Asia-Pacific faces higher capital costs for facility expansion. These tariffs are raising production expenses and slowing capacity additions. At the same time, they are encouraging localized equipment manufacturing, regional supply partnerships, and investment in domestic biologics processing infrastructure.

The spray-dried biologics market research report is one of a series of new reports from The Business Research Company that provides spray-dried biologics market statistics, including spray-dried biologics industry global market size, regional shares, competitors with a spray-dried biologics market share, detailed spray-dried biologics market segments, market trends and opportunities, and any further data you may need to thrive in the spray-dried biologics industry. This spray-dried biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The spray-dried biologics market size has grown rapidly in recent years. It will grow from $1.86 billion in 2025 to $2.08 billion in 2026 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to advancements in biologics formulation science, increasing biologic drug approvals, need for improved drug stability, expansion of vaccine manufacturing capacity, adoption of advanced pharmaceutical processing technologies.

The spray-dried biologics market size is expected to see rapid growth in the next few years. It will grow to $3.2 billion in 2030 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to increasing demand for non-injectable biologics, rising investments in dry powder delivery systems, expansion of global vaccine production, growing focus on cold-chain reduction, advancements in spray-drying equipment design. Major trends in the forecast period include increasing adoption of spray-drying for biologic stability, rising demand for inhalable and oral biologic formulations, expansion of continuous spray-drying processes, growing use of dry powder biologics in vaccines, enhanced focus on shelf-life extension.

Rising demand for biopharmaceuticals is anticipated to fuel expansion in the spray-dried biologics market. Biopharmaceuticals consist of therapeutic products sourced from biological origins, such as living cells, proteins, and various biomolecules. The need for biopharmaceuticals is growing amid a worldwide increase in chronic and complex diseases, heightening the demand for treatments with greater precision, enhanced effectiveness, and reduced systemic side effects. The spray-dried biologics sector is seeing heightened interest as the swift growth of biopharmaceuticals pushes firms toward scalable formulation methods that boost stability, extend shelf life, and optimize delivery. For example, in February 2025, the World Health Organization (WHO), a Switzerland-headquartered global public health body, reported that its 2023 essential medicines list (EML) featured 81 biologic therapies, representing over 15% of all essential medicines. Thus, the surging demand for biopharmaceuticals is propelling the spray-dried biologics market forward.

Major companies in the spray-dried biologics market are prioritizing technological innovations like drum dosing technology to boost dose precision, powder handling effectiveness, and dependable high-volume capsule filling. Drum dosing technology represents a sophisticated powder-filling technique that employs a rotating drum equipped with precisely designed dosing cavities and vacuum-assisted transfer to meter and place dry powders into capsules with high accuracy, supporting features such as uniform low-dose filling, better flow control for spray-dried powders, and scalable high-throughput operations. For example, in February 2024, Catalent Inc., a US-based contract development and manufacturing organization (CDMO), enhanced its inhalation manufacturing facility in the US by integrating potent capsule-filling capabilities driven by drum-based dosing systems and in-line advanced mass verification. The upgraded platform accommodates precise filling of engineered and spray-dried powders, incorporating real-time dose validation and controlled low-humidity processing. This improvement boosts manufacturing efficiency, product uniformity, and preparedness for commercial-scale production of spray-dried biologic dry-powder inhalation therapies.

In May 2023, Hovione, a Portugal-based integrated contract development and manufacturing organization (CDMO) focused on spray drying and particle engineering, teamed up with H&T Presspart to advance high-efficiency device technology for delivering dry powder inhalation formulations. This partnership allows Hovione to strengthen its expertise in engineered spray-dried and high-dose inhalation formulations by utilizing Presspart's Sunriser capsule-based dry powder inhaler platform, which boosts the performance and market readiness of inhalation therapies.

Major companies operating in the spray-dried biologics market are Thermo Fisher Scientific Inc., Evonik Industries AG, Lonza Group AG, GEA Group, Fareva Group, Almac Group Limited, Seqens Group, Fabbrica Italiana Sintetici S.p.A., CordenPharma International, Hovione FarmaCiencia SA, Veranova Inc., Pace Analytical Services LLC, Olon S.p.A., Nova Laboratories Ltd, Leukocare AG, Micro Sphere SA, Seran Bioscience LLC, CritiTech Particle Engineering Solutions LLC, Xedev BV, BUCHI Labortechnik AG.

North America was the largest region in the spray-dried biologics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spray-dried biologics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the spray-dried biologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The spray-dried biologics market consists of sales of peptide therapeutics, deoxyribonucleic acid vaccines, ribonucleic acid vaccines, nanobodies, antibody-drug conjugates, and recombinant proteins. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Spray-Dried Biologics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses spray-dried biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for spray-dried biologics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The spray-dried biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Spray-Dried Biologics Market Characteristics

3. Spray-Dried Biologics Market Supply Chain Analysis

4. Global Spray-Dried Biologics Market Trends And Strategies

5. Spray-Dried Biologics Market Analysis Of End Use Industries

6. Spray-Dried Biologics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Spray-Dried Biologics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Spray-Dried Biologics Total Addressable Market (TAM) Analysis for the Market

9. Spray-Dried Biologics Market Segmentation

10. Spray-Dried Biologics Market Regional And Country Analysis

11. Asia-Pacific Spray-Dried Biologics Market

12. China Spray-Dried Biologics Market

13. India Spray-Dried Biologics Market

14. Japan Spray-Dried Biologics Market

15. Australia Spray-Dried Biologics Market

16. Indonesia Spray-Dried Biologics Market

17. South Korea Spray-Dried Biologics Market

18. Taiwan Spray-Dried Biologics Market

19. South East Asia Spray-Dried Biologics Market

20. Western Europe Spray-Dried Biologics Market

21. UK Spray-Dried Biologics Market

22. Germany Spray-Dried Biologics Market

23. France Spray-Dried Biologics Market

24. Italy Spray-Dried Biologics Market

25. Spain Spray-Dried Biologics Market

26. Eastern Europe Spray-Dried Biologics Market

27. Russia Spray-Dried Biologics Market

28. North America Spray-Dried Biologics Market

29. USA Spray-Dried Biologics Market

30. Canada Spray-Dried Biologics Market

31. South America Spray-Dried Biologics Market

32. Brazil Spray-Dried Biologics Market

33. Middle East Spray-Dried Biologics Market

34. Africa Spray-Dried Biologics Market

35. Spray-Dried Biologics Market Regulatory and Investment Landscape

36. Spray-Dried Biologics Market Competitive Landscape And Company Profiles

37. Spray-Dried Biologics Market Other Major And Innovative Companies

38. Global Spray-Dried Biologics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Spray-Dried Biologics Market

40. Spray-Dried Biologics Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기